Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Edwin Asturias

Concepts (450)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Guatemala
50
2024
313
4.120
 Why?
Microcephaly
5
2024
87
2.830
 Why?
Zika Virus Infection
6
2024
155
2.760
 Why?
Vaccines
7
2024
398
2.480
 Why?
Influenza, Human
8
2025
601
2.420
 Why?
Rural Population
15
2024
513
2.280
 Why?
Poliovirus Vaccine, Inactivated
6
2018
28
2.190
 Why?
Vaccination
16
2025
1347
2.060
 Why?
Poliomyelitis
8
2018
36
1.960
 Why?
Poliovirus Vaccine, Oral
7
2018
25
1.810
 Why?
Zika Virus
5
2024
118
1.780
 Why?
Dengue
6
2024
69
1.630
 Why?
Infant
41
2025
8975
1.600
 Why?
Virus Shedding
9
2024
48
1.300
 Why?
Viral Vaccines
3
2018
94
1.210
 Why?
Child Development
3
2022
457
1.210
 Why?
Caliciviridae Infections
2
2018
17
1.140
 Why?
Norovirus
2
2018
23
1.130
 Why?
Poliovirus
6
2018
82
1.090
 Why?
Haemophilus Vaccines
5
2016
28
1.060
 Why?
Gastroenteritis
2
2017
67
1.060
 Why?
Dengue Virus
6
2024
41
1.030
 Why?
Reminder Systems
2
2019
173
1.010
 Why?
Text Messaging
2
2019
149
0.980
 Why?
Growth Disorders
2
2023
80
0.960
 Why?
Child, Preschool
28
2025
10456
0.960
 Why?
Health Knowledge, Attitudes, Practice
5
2023
1276
0.940
 Why?
Hepatitis B Vaccines
4
2016
47
0.930
 Why?
Fever
2
2017
298
0.920
 Why?
Immunization Schedule
5
2017
197
0.870
 Why?
Streptococcal Vaccines
1
2023
6
0.860
 Why?
Humans
94
2025
129144
0.850
 Why?
Immunization
4
2023
411
0.830
 Why?
Meningitis, Meningococcal
1
2022
6
0.810
 Why?
Cell Phone
3
2019
70
0.800
 Why?
Neisseria meningitidis
1
2022
23
0.800
 Why?
Meningococcal Infections
1
2022
24
0.800
 Why?
Child
27
2025
20768
0.780
 Why?
Neurodevelopmental Disorders
1
2024
155
0.780
 Why?
Meningococcal Vaccines
1
2022
54
0.770
 Why?
Family Characteristics
5
2025
178
0.750
 Why?
Streptococcal Infections
1
2023
148
0.730
 Why?
Prospective Studies
16
2025
7117
0.730
 Why?
Antibodies, Neutralizing
4
2017
265
0.690
 Why?
Pregnancy Complications, Infectious
2
2022
367
0.690
 Why?
Virus Diseases
1
2022
210
0.680
 Why?
Rural Health Services
2
2019
111
0.670
 Why?
Endpoint Determination
1
2020
76
0.670
 Why?
Female
54
2025
68494
0.650
 Why?
Diarrhea
5
2023
180
0.650
 Why?
Infant, Newborn
14
2024
5736
0.640
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
3
2016
25
0.640
 Why?
Immunity, Humoral
3
2017
118
0.640
 Why?
Influenza Vaccines
3
2021
532
0.630
 Why?
Contraception
4
2022
153
0.630
 Why?
Adolescent Health
1
2019
39
0.610
 Why?
Immunity, Mucosal
2
2016
94
0.600
 Why?
Arbovirus Infections
1
2018
19
0.600
 Why?
Patient Acceptance of Health Care
3
2020
757
0.600
 Why?
Community Health Services
2
2019
226
0.590
 Why?
Sentinel Surveillance
2
2017
41
0.590
 Why?
Haemophilus influenzae type b
2
2014
10
0.580
 Why?
Carrier State
3
2014
60
0.570
 Why?
Urban Health Services
1
2017
61
0.550
 Why?
Immunogenicity, Vaccine
1
2017
27
0.550
 Why?
Male
43
2025
63456
0.520
 Why?
Consumer Product Safety
1
2016
31
0.520
 Why?
Community Health Planning
1
2016
42
0.510
 Why?
Neonatal Screening
1
2017
163
0.510
 Why?
Public-Private Sector Partnerships
1
2016
42
0.510
 Why?
Physician Assistants
1
2017
88
0.500
 Why?
Family Planning Services
3
2022
87
0.490
 Why?
Anemia, Hemolytic
1
2015
16
0.490
 Why?
Population Health
1
2016
46
0.490
 Why?
Parents
3
2023
1308
0.480
 Why?
Schools
1
2019
439
0.480
 Why?
Latin America
5
2018
87
0.480
 Why?
Mobile Applications
1
2017
160
0.470
 Why?
Post-Exposure Prophylaxis
1
2014
8
0.470
 Why?
Castleman Disease
1
2014
13
0.460
 Why?
Pregnancy
13
2024
6392
0.460
 Why?
Advisory Committees
1
2016
216
0.460
 Why?
Exanthema
1
2015
74
0.460
 Why?
Herpes Zoster
2
2015
317
0.460
 Why?
Serogroup
4
2018
33
0.460
 Why?
Sexual Behavior
1
2019
481
0.450
 Why?
Needs Assessment
2
2016
357
0.450
 Why?
Haemophilus Infections
1
2014
39
0.450
 Why?
Caregivers
1
2021
802
0.440
 Why?
Population Surveillance
1
2017
438
0.440
 Why?
Brain Diseases
1
2015
136
0.440
 Why?
Adolescent Behavior
1
2019
506
0.430
 Why?
Streptococcus pneumoniae
4
2024
159
0.430
 Why?
Bacterial Capsules
2
2014
28
0.430
 Why?
Calcitonin
1
2013
27
0.430
 Why?
Receptors, Interleukin-6
1
2013
37
0.420
 Why?
Global Health
1
2016
327
0.420
 Why?
Product Surveillance, Postmarketing
1
2013
62
0.420
 Why?
Health Behavior
1
2019
740
0.420
 Why?
Adverse Drug Reaction Reporting Systems
1
2013
74
0.410
 Why?
Adolescent
20
2025
20297
0.410
 Why?
Antibodies, Bacterial
2
2014
137
0.400
 Why?
Protein Precursors
1
2013
128
0.400
 Why?
Bacterial Infections
2
2013
235
0.400
 Why?
Hospitalization
7
2022
2052
0.390
 Why?
Feces
8
2018
441
0.390
 Why?
Intestines
4
2018
347
0.370
 Why?
Antibodies, Monoclonal, Humanized
2
2014
757
0.370
 Why?
Diet
1
2019
1212
0.360
 Why?
Intestinal Mucosa
1
2016
589
0.360
 Why?
Young Adult
15
2025
12385
0.360
 Why?
Adult
27
2025
35469
0.350
 Why?
Community-Acquired Infections
2
2024
160
0.350
 Why?
Antigens, Viral
2
2024
178
0.340
 Why?
Contraceptive Agents
2
2021
65
0.340
 Why?
Pleural Effusion
2
2024
51
0.340
 Why?
Saccharum
3
2020
81
0.330
 Why?
Surveys and Questionnaires
5
2021
5382
0.320
 Why?
Hepatitis B Antibodies
1
2009
11
0.320
 Why?
Immunosuppressive Agents
1
2013
854
0.300
 Why?
Agriculture
2
2020
91
0.300
 Why?
Delivery, Obstetric
2
2019
136
0.300
 Why?
Dengue Vaccines
2
2018
9
0.300
 Why?
Multiplex Polymerase Chain Reaction
2
2019
51
0.300
 Why?
Antibodies, Viral
7
2022
601
0.290
 Why?
Malnutrition
1
2009
79
0.290
 Why?
Urban Population
3
2019
441
0.290
 Why?
World Health Organization
3
2017
110
0.280
 Why?
Appointments and Schedules
2
2019
84
0.280
 Why?
Pneumonia, Pneumococcal
2
2024
42
0.270
 Why?
RNA, Viral
2
2021
619
0.270
 Why?
Primary Health Care
1
2017
1678
0.270
 Why?
Cross-Sectional Studies
5
2023
5044
0.260
 Why?
Seroconversion
2
2017
46
0.260
 Why?
Acute Disease
3
2019
978
0.260
 Why?
Immunization Programs
3
2024
214
0.250
 Why?
Glomerular Filtration Rate
2
2020
711
0.240
 Why?
Viruses
2
2023
100
0.230
 Why?
Cohort Studies
5
2024
5408
0.230
 Why?
Viral Load
2
2024
448
0.230
 Why?
Anthropometry
2
2022
204
0.230
 Why?
Vaccines, Conjugate
2
2022
63
0.230
 Why?
Meningitis, Haemophilus
1
2003
6
0.220
 Why?
Culex
1
2023
13
0.220
 Why?
Postpartum Period
3
2022
332
0.220
 Why?
Ritonavir
1
2024
73
0.210
 Why?
Streptococcus pyogenes
1
2023
39
0.210
 Why?
Aedes
1
2023
57
0.210
 Why?
Incidence
4
2022
2635
0.200
 Why?
Postnatal Care
2
2021
71
0.200
 Why?
Anti-Infective Agents
2
2020
247
0.200
 Why?
Propensity Score
1
2024
263
0.200
 Why?
Psychometrics
3
2021
691
0.200
 Why?
Vomiting
1
2023
128
0.200
 Why?
Seasons
2
2025
494
0.200
 Why?
Travel
3
2015
121
0.200
 Why?
Seroepidemiologic Studies
2
2022
156
0.200
 Why?
Quality Improvement
5
2022
1095
0.190
 Why?
Cough
1
2023
116
0.190
 Why?
Vital Signs
1
2022
41
0.190
 Why?
Regression Analysis
2
2022
992
0.190
 Why?
Biomarkers
1
2013
3963
0.190
 Why?
Health Services Accessibility
2
2020
899
0.190
 Why?
Herpesvirus 3, Human
2
2015
331
0.190
 Why?
Meningitis, Bacterial
2
2015
47
0.190
 Why?
Polymerase Chain Reaction
1
2024
1033
0.190
 Why?
Escherichia coli Vaccines
2
2013
3
0.190
 Why?
Drug Therapy, Combination
3
2016
1040
0.190
 Why?
Vaccines, Combined
3
2024
48
0.180
 Why?
Health Promotion
2
2019
719
0.180
 Why?
Cesarean Section
2
2019
181
0.180
 Why?
Attitude
1
2023
252
0.180
 Why?
Midwifery
1
2022
48
0.180
 Why?
Influenza A Virus, H3N2 Subtype
1
2021
43
0.180
 Why?
Malaria Vaccines
1
2020
8
0.180
 Why?
Drug-Related Side Effects and Adverse Reactions
2
2013
252
0.180
 Why?
Outpatients
1
2024
366
0.180
 Why?
Reproducibility of Results
4
2021
3077
0.170
 Why?
Yellow fever virus
1
2020
3
0.170
 Why?
Immunologic Deficiency Syndromes
2
2015
64
0.170
 Why?
Birth Intervals
1
2020
21
0.170
 Why?
Emergency Service, Hospital
2
2022
1896
0.170
 Why?
Maternal Health Services
1
2022
91
0.170
 Why?
Yellow Fever
1
2020
7
0.170
 Why?
Risk Factors
9
2025
9740
0.170
 Why?
Molecular Diagnostic Techniques
1
2021
98
0.170
 Why?
Absenteeism
1
2020
47
0.170
 Why?
Cesarean Section, Repeat
1
2019
11
0.170
 Why?
Intensive Care, Neonatal
1
2020
40
0.170
 Why?
Vaccination Refusal
1
2020
70
0.170
 Why?
Vaginal Birth after Cesarean
1
2019
25
0.160
 Why?
Drug Discovery
1
2020
130
0.160
 Why?
Agricultural Workers' Diseases
1
2020
33
0.160
 Why?
Contraception Behavior
1
2020
97
0.160
 Why?
Language Tests
1
2019
33
0.160
 Why?
Real-Time Polymerase Chain Reaction
1
2020
328
0.160
 Why?
Maternal Age
1
2019
124
0.160
 Why?
Language Development Disorders
1
2019
46
0.160
 Why?
Motor Skills
1
2020
92
0.160
 Why?
Arboviruses
1
2018
13
0.150
 Why?
Clinical Trials as Topic
1
2023
1003
0.150
 Why?
Thinness
1
2019
89
0.150
 Why?
Puerto Rico
1
2018
52
0.150
 Why?
Entamoeba histolytica
1
2018
7
0.150
 Why?
Heat Stress Disorders
1
2019
69
0.150
 Why?
Pregnancy in Adolescence
1
2019
80
0.150
 Why?
Farmers
1
2019
67
0.150
 Why?
Pregnant Women
1
2019
114
0.150
 Why?
Vulnerable Populations
1
2019
156
0.140
 Why?
Treatment Refusal
1
2018
89
0.140
 Why?
Mothers
3
2022
730
0.140
 Why?
Chikungunya Fever
1
2018
76
0.140
 Why?
Neoplasms
2
2016
2442
0.140
 Why?
Intensive Care Units, Neonatal
1
2020
226
0.140
 Why?
Child Health
1
2019
146
0.140
 Why?
Occupational Health
2
2018
192
0.140
 Why?
Vaccines, Attenuated
1
2017
125
0.140
 Why?
Educational Status
1
2019
469
0.140
 Why?
Colorado
3
2024
4402
0.140
 Why?
Anti-Bacterial Agents
3
2024
1702
0.130
 Why?
Public Health
2
2018
483
0.130
 Why?
Diagnostic Tests, Routine
1
2018
102
0.130
 Why?
Poliovirus Vaccines
1
2016
5
0.130
 Why?
Health Surveys
1
2019
493
0.130
 Why?
Pneumococcal Infections
2
2016
111
0.130
 Why?
HIV Infections
2
2014
2721
0.130
 Why?
Central Nervous System Viral Diseases
1
2018
73
0.130
 Why?
Child Behavior
1
2019
235
0.130
 Why?
Myelitis
1
2018
98
0.130
 Why?
Panama
1
2016
12
0.130
 Why?
Databases, Factual
3
2019
1266
0.130
 Why?
Colombia
1
2016
36
0.130
 Why?
Dominican Republic
1
2016
23
0.130
 Why?
Neuromuscular Diseases
1
2018
105
0.130
 Why?
Community Health Nursing
1
2016
59
0.130
 Why?
Peru
1
2016
53
0.130
 Why?
Risk-Taking
1
2019
346
0.130
 Why?
Measles-Mumps-Rubella Vaccine
1
2016
41
0.130
 Why?
Host-Pathogen Interactions
1
2019
351
0.130
 Why?
Sanitation
1
2016
52
0.130
 Why?
Anemia, Hemolytic, Autoimmune
1
2015
15
0.120
 Why?
Water Supply
1
2016
74
0.120
 Why?
Rotavirus Vaccines
1
2016
49
0.120
 Why?
Learning
1
2020
401
0.120
 Why?
Health Services Needs and Demand
1
2017
263
0.120
 Why?
Occupational Exposure
1
2019
299
0.120
 Why?
Single-Blind Method
1
2016
271
0.120
 Why?
Chickenpox
1
2016
80
0.120
 Why?
Analysis of Variance
1
2018
1288
0.120
 Why?
Patient Preference
1
2017
184
0.120
 Why?
Typhoid Fever
1
2015
10
0.120
 Why?
Health Information Systems
1
2015
18
0.120
 Why?
Enterovirus Infections
1
2018
171
0.120
 Why?
Community Participation
1
2016
124
0.120
 Why?
Data Collection
1
2018
647
0.120
 Why?
Education, Nursing
1
2016
90
0.120
 Why?
Disease Outbreaks
1
2018
349
0.120
 Why?
Antibody Affinity
1
2014
59
0.110
 Why?
Biomedical Research
1
2020
637
0.110
 Why?
Malaria
1
2015
59
0.110
 Why?
Fatal Outcome
1
2015
299
0.110
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2014
86
0.110
 Why?
Overweight
1
2019
531
0.110
 Why?
Middle Aged
9
2025
31050
0.110
 Why?
Vincristine
1
2014
108
0.110
 Why?
Cyclophosphamide
1
2014
232
0.110
 Why?
Renal Insufficiency, Chronic
1
2020
566
0.110
 Why?
Severity of Illness Index
2
2020
2736
0.110
 Why?
History, 21st Century
1
2014
183
0.110
 Why?
Mucocutaneous Lymph Node Syndrome
1
2014
90
0.110
 Why?
Enterotoxins
1
2013
87
0.110
 Why?
Rituximab
1
2014
164
0.110
 Why?
Prednisone
1
2014
233
0.110
 Why?
Universities
1
2016
407
0.110
 Why?
Students
1
2019
579
0.110
 Why?
Calcitonin Gene-Related Peptide
1
2013
40
0.110
 Why?
History, 20th Century
1
2014
291
0.110
 Why?
Case-Control Studies
1
2021
3372
0.110
 Why?
Bacterial Toxins
1
2013
104
0.100
 Why?
Causality
1
2013
117
0.100
 Why?
Education, Medical
1
2016
244
0.100
 Why?
Socioeconomic Factors
1
2017
1208
0.100
 Why?
Health Policy
1
2016
351
0.100
 Why?
Communicable Diseases
1
2015
147
0.100
 Why?
Doxorubicin
1
2014
328
0.100
 Why?
Delivery of Health Care
1
2019
892
0.100
 Why?
Lymphocytes
1
2014
378
0.100
 Why?
Practice Guidelines as Topic
1
2020
1496
0.100
 Why?
Gene Expression Profiling
1
2019
1683
0.100
 Why?
Escherichia coli Proteins
1
2013
178
0.100
 Why?
Sensitivity and Specificity
3
2024
1833
0.100
 Why?
Lymph Nodes
1
2014
470
0.090
 Why?
Aged, 80 and over
1
2023
7037
0.090
 Why?
Program Evaluation
1
2016
872
0.090
 Why?
Acute Kidney Injury
1
2019
789
0.090
 Why?
Hypertension
1
2020
1242
0.090
 Why?
Kidney
1
2018
1384
0.090
 Why?
Interleukin-6
1
2014
720
0.090
 Why?
Decision Support Systems, Clinical
1
2013
204
0.090
 Why?
United States
6
2025
13825
0.080
 Why?
Clinical Competence
1
2017
1013
0.080
 Why?
Influenza A Virus, H1N1 Subtype
1
2011
146
0.080
 Why?
Immunization, Secondary
1
2010
87
0.080
 Why?
Escherichia coli
1
2013
766
0.080
 Why?
Physicians
1
2017
859
0.080
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2007
37
0.070
 Why?
Creatinine
2
2020
490
0.070
 Why?
Penicillins
1
2007
57
0.070
 Why?
Drug Resistance, Multiple, Bacterial
1
2007
71
0.070
 Why?
Nasopharynx
1
2007
68
0.070
 Why?
Time Factors
4
2025
6541
0.070
 Why?
Aged
5
2025
21997
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
1554
0.060
 Why?
Prevalence
2
2025
2554
0.060
 Why?
Cities
2
2016
105
0.060
 Why?
Contact Tracing
1
2025
23
0.060
 Why?
Drug Administration Schedule
1
2007
767
0.060
 Why?
Basic Reproduction Number
1
2025
5
0.060
 Why?
Neuropsychological Tests
2
2020
1014
0.060
 Why?
Tomography, X-Ray Computed
1
2014
2511
0.060
 Why?
Sepsis
2
2003
572
0.060
 Why?
Mexico
3
2013
190
0.060
 Why?
Mosquito Vectors
1
2023
25
0.050
 Why?
Treatment Outcome
4
2020
10192
0.050
 Why?
Policy Making
1
2024
88
0.050
 Why?
China
1
2024
192
0.050
 Why?
Haemophilus influenzae
1
2003
63
0.050
 Why?
Antiviral Agents
2
2024
712
0.050
 Why?
Chickens
1
2023
189
0.050
 Why?
Developing Countries
2
2016
284
0.050
 Why?
Randomized Controlled Trials as Topic
2
2019
1363
0.050
 Why?
Bayes Theorem
1
2025
373
0.050
 Why?
Pandemics
1
2011
1482
0.050
 Why?
Cross Reactions
1
2022
132
0.050
 Why?
Longitudinal Studies
2
2020
2716
0.050
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2024
219
0.050
 Why?
Mammals
1
2023
272
0.050
 Why?
Administration, Cutaneous
2
2013
124
0.040
 Why?
Hospitals
2
2016
630
0.040
 Why?
Paraguay
1
2020
2
0.040
 Why?
Sri Lanka
1
2020
7
0.040
 Why?
Endemic Diseases
1
2020
31
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2022
832
0.040
 Why?
Reagent Kits, Diagnostic
1
2020
43
0.040
 Why?
Translations
1
2020
17
0.040
 Why?
Home Health Nursing
1
2019
10
0.040
 Why?
Hospitals, Pediatric
2
2015
508
0.040
 Why?
Specific Gravity
1
2019
11
0.040
 Why?
Prenatal Care
1
2022
274
0.040
 Why?
Parity
1
2019
120
0.040
 Why?
Child Language
1
2019
25
0.040
 Why?
Translating
1
2019
37
0.040
 Why?
Rural Health
1
2019
70
0.040
 Why?
Dehydration
1
2019
49
0.040
 Why?
Electrolytes
1
2019
59
0.040
 Why?
Parasites
1
2019
44
0.040
 Why?
Reproductive Health
1
2019
83
0.040
 Why?
Culturally Competent Care
1
2019
57
0.040
 Why?
Infectious Disease Transmission, Vertical
1
2020
170
0.040
 Why?
Work Capacity Evaluation
1
2018
11
0.040
 Why?
Bacteria
2
2019
813
0.040
 Why?
Feasibility Studies
1
2022
865
0.040
 Why?
House Calls
1
2019
123
0.040
 Why?
Retrospective Studies
4
2020
14450
0.040
 Why?
Coinfection
1
2019
131
0.040
 Why?
Chi-Square Distribution
1
2019
514
0.040
 Why?
Education, Medical, Continuing
1
2019
122
0.040
 Why?
Adjuvants, Immunologic
1
2019
221
0.040
 Why?
Pregnancy Outcome
1
2020
389
0.040
 Why?
Licensure
1
2017
12
0.040
 Why?
Chromatography, Affinity
1
2017
83
0.040
 Why?
Choice Behavior
1
2019
164
0.040
 Why?
Epitope Mapping
1
2017
57
0.030
 Why?
Francisella
1
1997
2
0.030
 Why?
Paralysis
1
2018
69
0.030
 Why?
Parenteral Nutrition
1
1998
104
0.030
 Why?
Gastrointestinal Tract
1
2019
185
0.030
 Why?
Counseling
1
2020
383
0.030
 Why?
Granulomatous Disease, Chronic
1
1997
53
0.030
 Why?
Sequence Alignment
1
2017
332
0.030
 Why?
Gram-Negative Bacterial Infections
1
1997
45
0.030
 Why?
Women's Health
1
2019
364
0.030
 Why?
Double-Blind Method
2
2013
1874
0.030
 Why?
Enterovirus D, Human
1
2018
82
0.030
 Why?
ROC Curve
1
2017
502
0.030
 Why?
Acyclovir
1
2016
99
0.030
 Why?
Chile
1
2015
21
0.030
 Why?
Cholestasis
1
1998
232
0.030
 Why?
Age Distribution
1
2016
372
0.030
 Why?
IgG Deficiency
2
2006
7
0.030
 Why?
Sex Distribution
1
2016
359
0.030
 Why?
IgA Deficiency
2
2006
6
0.030
 Why?
Infusions, Intravenous
1
2016
399
0.030
 Why?
Residence Characteristics
1
2018
327
0.030
 Why?
Spleen
1
1997
506
0.030
 Why?
Pneumococcal Vaccines
1
2016
140
0.030
 Why?
Computational Biology
1
2019
596
0.030
 Why?
Healthy Volunteers
1
2015
200
0.030
 Why?
Pedigree
1
2015
486
0.030
 Why?
Blood Pressure
1
2021
1736
0.030
 Why?
Amino Acid Sequence
1
2017
2056
0.030
 Why?
Maternal-Fetal Exchange
1
2014
161
0.030
 Why?
Transcriptome
1
2019
874
0.030
 Why?
Europe
1
2013
363
0.030
 Why?
Checklist
1
2013
92
0.020
 Why?
High-Throughput Nucleotide Sequencing
1
2015
485
0.020
 Why?
Adrenal Cortex Hormones
1
2015
522
0.020
 Why?
Survival Analysis
1
2015
1268
0.020
 Why?
Survival Rate
1
2016
1869
0.020
 Why?
Lymphocyte Activation
1
2015
1109
0.020
 Why?
Oseltamivir
1
2011
11
0.020
 Why?
Oncology Service, Hospital
1
2011
16
0.020
 Why?
Comorbidity
1
2016
1544
0.020
 Why?
Nuclear Proteins
1
2015
658
0.020
 Why?
Smoking
1
2018
1499
0.020
 Why?
Antibodies, Monoclonal
1
2017
1363
0.020
 Why?
Drug Delivery Systems
1
2013
332
0.020
 Why?
El Salvador
1
2010
6
0.020
 Why?
Body Mass Index
1
2018
2272
0.020
 Why?
Animals
2
2023
35286
0.020
 Why?
Latex Fixation Tests
1
2008
3
0.020
 Why?
Brain Damage, Chronic
1
2008
20
0.020
 Why?
Coma
1
2008
32
0.020
 Why?
Leukocytosis
1
2008
32
0.020
 Why?
Bacteriological Techniques
1
2008
69
0.020
 Why?
DNA-Binding Proteins
1
2015
1445
0.020
 Why?
Cerebrospinal Fluid
1
2008
91
0.020
 Why?
Cells, Cultured
1
2015
4075
0.020
 Why?
Child Day Care Centers
1
2007
32
0.020
 Why?
Shock
1
2008
92
0.020
 Why?
Follow-Up Studies
1
2016
4882
0.020
 Why?
Risk Assessment
1
2016
3231
0.020
 Why?
Postoperative Complications
1
1998
2472
0.020
 Why?
Ethiopia
1
2006
35
0.020
 Why?
Microbial Sensitivity Tests
1
2007
347
0.020
 Why?
Bacteremia
1
2008
194
0.020
 Why?
Pakistan
1
2006
75
0.020
 Why?
Algorithms
1
2013
1613
0.020
 Why?
Antineoplastic Agents
1
2016
2045
0.010
 Why?
Common Variable Immunodeficiency
1
2004
26
0.010
 Why?
Ambulatory Care
1
2007
503
0.010
 Why?
Agammaglobulinemia
1
2004
33
0.010
 Why?
Brazil
1
2004
154
0.010
 Why?
United Kingdom
1
2004
257
0.010
 Why?
Confidence Intervals
1
2004
316
0.010
 Why?
Short Bowel Syndrome
1
1998
26
0.010
 Why?
Bilirubin
1
1998
96
0.010
 Why?
Liver Failure
1
1998
91
0.010
 Why?
Water Microbiology
1
1997
82
0.010
 Why?
Abscess
1
1997
73
0.010
 Why?
Asturias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (450) concept(s)
_
Co-Authors Expand Description
See all (51) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)